Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP711182.RAbMJtKUwUtKbErhv3BnOxg_DyMP7Lf9mCSmcr9LMLf68130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP711182.RAbMJtKUwUtKbErhv3BnOxg_DyMP7Lf9mCSmcr9LMLf68130_assertion type Assertion NP711182.RAbMJtKUwUtKbErhv3BnOxg_DyMP7Lf9mCSmcr9LMLf68130_head.
- NP711182.RAbMJtKUwUtKbErhv3BnOxg_DyMP7Lf9mCSmcr9LMLf68130_assertion description "[Immunolocalization of osteopontin showed that tissue samples from 61 patients with invasive ovarian cancer and 29 patients with borderline ovarian tumors expressed higher levels of osteopontin than tissue samples from 6 patients with benign tumors and samples of healthy ovarian epithelium from 3 patients (P =.03).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711182.RAbMJtKUwUtKbErhv3BnOxg_DyMP7Lf9mCSmcr9LMLf68130_provenance.
- NP711182.RAbMJtKUwUtKbErhv3BnOxg_DyMP7Lf9mCSmcr9LMLf68130_assertion evidence source_evidence_literature NP711182.RAbMJtKUwUtKbErhv3BnOxg_DyMP7Lf9mCSmcr9LMLf68130_provenance.
- NP711182.RAbMJtKUwUtKbErhv3BnOxg_DyMP7Lf9mCSmcr9LMLf68130_assertion SIO_000772 11926891 NP711182.RAbMJtKUwUtKbErhv3BnOxg_DyMP7Lf9mCSmcr9LMLf68130_provenance.
- NP711182.RAbMJtKUwUtKbErhv3BnOxg_DyMP7Lf9mCSmcr9LMLf68130_assertion wasDerivedFrom befree-20150227 NP711182.RAbMJtKUwUtKbErhv3BnOxg_DyMP7Lf9mCSmcr9LMLf68130_provenance.
- NP711182.RAbMJtKUwUtKbErhv3BnOxg_DyMP7Lf9mCSmcr9LMLf68130_assertion wasGeneratedBy ECO_0000203 NP711182.RAbMJtKUwUtKbErhv3BnOxg_DyMP7Lf9mCSmcr9LMLf68130_provenance.